Matthew K Szot - Net Worth and Insider Trading

Matthew K Szot Net Worth

The estimated net worth of Matthew K Szot is at least $18,426 dollars as of 2024-11-05. Matthew K Szot is the EVP Finance & Admin and CFO of S&W Seed Co and owns about 6,283 shares of S&W Seed Co (SANW) stock worth over $16,838. Matthew K Szot is also the Director of NAYA Biosciences and owns about 1,959 shares of NAYA Biosciences (NAYA) stock worth over $1,587. Details can be seen in Matthew K Szot's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew K Szot has not made any transactions after 2022-06-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Matthew K Szot

Matthew K Szot Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew K Szot owns 7 companies in total, including S&W Seed Co (SANW) , NAYA Biosciences (NAYA) , and SenesTech Inc (SNES) among others .

Click here to see the complete history of Matthew K Szot’s form 4 insider trades.

Insider Ownership Summary of Matthew K Szot

Ticker	Comapny	Transaction Date	Type of Owner
SANW	S&W Seed Co	2020-05-20	VP Finance and CFO
NAYA	NAYA Biosciences	2022-06-01	director
SNES	SenesTech Inc	2016-12-07	director
		2019-03-31	director
		2011-07-22	Chief Financial Officer
		2009-01-22	Chief Financial Officer
		2023-01-19	Chief Financial Officer

Matthew K Szot Latest Holdings Summary

Matthew K Szot currently owns a total of 2 stocks. Among these stocks, Matthew K Szot owns 6,283 shares of S&W Seed Co (SANW) as of May 20, 2020, with a value of $16,838 and a weighting of 91.39%. Matthew K Szot also owns 1,959 shares of NAYA Biosciences (NAYA) as of June 1, 2022, with a value of $1,587 and a weighting of 8.61%.

Latest Holdings of Matthew K Szot

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SANW	S&W Seed Co	2020-05-20	6,283	2.68	16,838
NAYA	NAYA Biosciences	2022-06-01	1,959	0.81	1,587

Holding Weightings of Matthew K Szot

Matthew K Szot Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew K Szot has made a total of 2 transactions in S&W Seed Co (SANW) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in S&W Seed Co is the acquisition of 53 shares on May 20, 2020, which cost Matthew K Szot around $2,040.

According to the SEC Form 4 filings, Matthew K Szot has made a total of 1 transactions in NAYA Biosciences (NAYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NAYA Biosciences is the acquisition of 724 shares on June 1, 2022, which cost Matthew K Szot around $13,750.

Insider Trading History of Matthew K Szot

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew K Szot Trading Performance

GuruFocus tracks the stock performance after each of Matthew K Szot's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew K Szot is 10.33%. GuruFocus also compares Matthew K Szot's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew K Szot within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Matthew K Szot's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Matthew K Szot

Average Return

Average return per transaction

Outperforming Transactions

2 out of 3 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-2.58
Relative Return to S&P 500(%)	-8.37

Matthew K Szot Ownership Network

Ownership Network List of Matthew K Szot

No Data

Ownership Network Relation of Matthew K Szot

Matthew K Szot Owned Company Details

What does S&W Seed Co do?

Who are the key executives at S&W Seed Co?

Matthew K Szot is the VP Finance and CFO of S&W Seed Co. Other key executives at S&W Seed Co include Interim CFO Vanessa Baughman , 10 percent owner Wynnefield Partners Small Cap Value Lp , and 10 percent owner & other: See remarks Jennifer C. Price .

S&W Seed Co (SANW) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of S&W Seed Co (SANW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of S&W Seed Co (SANW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

S&W Seed Co (SANW)'s detailed insider trading history can be found in Insider Trading Tracker table.

S&W Seed Co Insider Transactions

No Available Data

What does NAYA Biosciences do?

Who are the key executives at NAYA Biosciences?

Matthew K Szot is the director of NAYA Biosciences. Other key executives at NAYA Biosciences include Chief Financial Officer Andrea Goren , 10 percent owner Awm Investment Company, Inc. , and director & Medical Director Kevin Doody .

NAYA Biosciences (NAYA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NAYA Biosciences (NAYA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NAYA Biosciences (NAYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NAYA Biosciences (NAYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

NAYA Biosciences Insider Transactions

No Available Data

What does SenesTech Inc do?

Who are the key executives at SenesTech Inc?

Matthew K Szot is the director of SenesTech Inc. Other key executives at SenesTech Inc include director & Chief Executive Officer Joel Lee Fruendt , director & Chief Executive Officer Kenneth S Siegel , and Chief Strategy Officer Nicole C Williams .

SenesTech Inc (SNES) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of SenesTech Inc (SNES) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SenesTech Inc (SNES) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SenesTech Inc (SNES)'s detailed insider trading history can be found in Insider Trading Tracker table.

SenesTech Inc Insider Transactions

No Available Data

What does Eastside Distilling Inc do?

Who are the key executives at Eastside Distilling Inc?

Matthew K Szot is the director of Eastside Distilling Inc. Other key executives at Eastside Distilling Inc include 10 percent owner Bigger Capital Fund L P , 10 percent owner District 2 Capital Fund Lp , and 10 percent owner District 2 Capital Lp .

Eastside Distilling Inc (EAST) Insider Trades Summary

Over the past 18 months, Matthew K Szot made no insider transaction in Eastside Distilling Inc (EAST). Other recent insider transactions involving Eastside Distilling Inc (EAST) include a net sale of 18,031 shares made by Eric J. Finnsson , a net sale of 1,054,091 shares made by Bigger Capital Fund L P , and a net sale of 5,000 shares made by Elizabeth Ann Levy-navarro .

In summary, during the past 3 months, insiders sold 1,054,091 shares of Eastside Distilling Inc (EAST) in total and bought 0 shares, with a net sale of 1,054,091 shares. During the past 18 months, 1,077,122 shares of Eastside Distilling Inc (EAST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,077,122 shares.

Eastside Distilling Inc (EAST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eastside Distilling Inc Insider Transactions

No Available Data

What does Mobivity Holdings Corp do?

Who are the key executives at Mobivity Holdings Corp?

Matthew K Szot is the Chief Financial Officer of Mobivity Holdings Corp. Other key executives at Mobivity Holdings Corp include CHIEF FINANCIAL OFFICER William T. Sanchez , Interim CFO Skye Fossey-tomaske , and 10 percent owner Talkot Capital, Llc .

Mobivity Holdings Corp (MFON) Insider Trades Summary

Over the past 18 months, Matthew K Szot made no insider transaction in Mobivity Holdings Corp (MFON). Other recent insider transactions involving Mobivity Holdings Corp (MFON) include a net purchase of 4,876,126 shares made by Thomas B Akin ,

In summary, during the past 3 months, insiders sold 0 shares of Mobivity Holdings Corp (MFON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mobivity Holdings Corp (MFON) were sold and 4,876,126 shares were bought by its insiders, resulting in a net purchase of 4,876,126 shares.

Mobivity Holdings Corp (MFON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mobivity Holdings Corp Insider Transactions

No Available Data

What does MMEX Resources Corp do?

Who are the key executives at MMEX Resources Corp?

Matthew K Szot is the Chief Financial Officer of MMEX Resources Corp. Other key executives at MMEX Resources Corp include 10 percent owner Nabil Katabi , director & President & CEO Jack Walton Hanks , and director & Chairman of the Board Tydus Richards .

MMEX Resources Corp (MMEX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MMEX Resources Corp (MMEX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MMEX Resources Corp (MMEX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MMEX Resources Corp (MMEX)'s detailed insider trading history can be found in Insider Trading Tracker table.

MMEX Resources Corp Insider Transactions

No Available Data

What does Cadrenal Therapeutics Inc do?

Who are the key executives at Cadrenal Therapeutics Inc?

Matthew K Szot is the Chief Financial Officer of Cadrenal Therapeutics Inc. Other key executives at Cadrenal Therapeutics Inc include director & 10 percent owner & CEO and Chairman Quang X Pham , and Chief Medical Officer Douglas W Losordo .

Cadrenal Therapeutics Inc (CVKD) Insider Trades Summary

Over the past 18 months, Matthew K Szot made no insider transaction in Cadrenal Therapeutics Inc (CVKD). Other recent insider transactions involving Cadrenal Therapeutics Inc (CVKD) include a net purchase of 110,000 shares made by Quang X Pham , and a net purchase of 20,000 shares made by John Raymond Murphy .

In summary, during the past 3 months, insiders sold 0 shares of Cadrenal Therapeutics Inc (CVKD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cadrenal Therapeutics Inc (CVKD) were sold and 8,667 shares were bought by its insiders, resulting in a net purchase of 8,667 shares.

Cadrenal Therapeutics Inc (CVKD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cadrenal Therapeutics Inc Insider Transactions

No Available Data

Matthew K Szot Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew K Szot. You might contact Matthew K Szot via mailing address: 802 North Douty Street, Hanford Ca 93230.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.